JIP
NVS icon

Jaffetilchin Investment Partners’s Novartis NVS Stock Holding History

Jaffetilchin Investment Partners’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-145
Closed -$16.7K – 971
2024
Q3 		$16.7K Buy
+145
New +$16.5K ﹤0.01% 803

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Jaffetilchin Investment Partners's NVS Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Novartis (NVS) in Q4 2024, closing a stake of 145 shares — an estimated $16.7K sold.

Jaffetilchin Investment Partners first reported a position in NVS in Q3 2024 and held it in 1 quarter. The position peaked at $16.7K in Q3 2024. 1,341 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 145 Novartis shares in Q4 2024, an estimated $16.7K.
  • Jaffetilchin Investment Partners first reported a position in Novartis in Q3 2024 and held it in 1 quarter.
  • Jaffetilchin Investment Partners's Novartis position peaked at $16.7K in Q3 2024.
  • 1,341 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.